Common Contracts
2 similar Research Collaboration and License Agreement contracts by TRex Bio, Inc.
RESEARCH COLLABORATION AND LICENSE AGREEMENT BY AND AMONG ELI LILLY AND COMPANY, TREX BIO, INC., AND TREX HOLDINGS INC.Research Collaboration and License Agreement • September 18th, 2026 • TRex Bio, Inc. • Biological products, (no disgnostic substances) • New York
This Research Collaboration and License Agreement (this “Agreement”) is entered into as of January 6, 2023 (the “Execution Date”) and is effective as of the Antitrust Clearance Date (the “Effective Date”) except for Article 9 hereof, which shall be effective as of the Execution Date, by and among, on the one hand, Eli Lilly and Company, an Indiana corporation (“Lilly”), and, on the other hand, TRex Bio Inc., a Delaware company (“TRex”), and solely for purposes of Section 14.9, TRex Holdings Inc., a Delaware company (“Parent”). Lilly and TRex are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
CERTAIN INFORMATION IDENTIFIED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (1) NOT MATERIAL AND (2) OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. RESEARCH COLLABORATION AND LICENSE AGREEMENT BY AND AMONG ELI LILLY...Research Collaboration and License Agreement • July 31st, 2026 • TRex Bio, Inc. • Biological products, (no disgnostic substances) • New York
This Research Collaboration and License Agreement (this “Agreement”) is entered into as of January 6, 2023 (the “Execution Date”) and is effective as of the Antitrust Clearance Date (the “Effective Date”) except for Article 9 hereof, which shall be effective as of the Execution Date, by and among, on the one hand, Eli Lilly and Company, an Indiana corporation (“Lilly”), and, on the other hand, TRex Bio Inc., a Delaware company (“TRex”), and solely for purposes of Section 14.9, TRex Holdings Inc., a Delaware company (“Parent”). Lilly and TRex are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”